• CAPE NF-κB Assay Workflow and Applications

  2026-09-16

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical perturbation tool for dissecting NF-κB-dependent inflammation, angiogenesis, and tumor invasion. This workflow connects CAPE dose-response testing with the Stat3–NF-κB biology of Fyn-driven neurodegeneration while clearly separating established evidence from proposed assay extensions.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-09-16

  Use the Annexin V-Cy5 Apoptosis Kit to separate genuine phosphatidylserine-positive cell death from lysosomal stress in demanding microglial models. Its rapid staining workflow supports both flow cytometry apoptosis detection and fluorescence microscopy apoptosis analysis, making it useful for time-course and mechanism-focused experiments.

• DiscoveryProbe L1042: From Hits to Immune Mechanisms

  2026-09-15

  DiscoveryProbe Immunology/Inflammation Compound Library L1042 connects multiparametric PBMC phenotyping with mechanism-oriented immunomodulator screening. This guide explains how to distinguish pathway activity from cytotoxicity, prioritize targets, and translate immune phenotypes into actionable follow-up experiments.

• Belinostat (PXD101) and the Acetylation–Splicing Axis

  2026-09-15

  Belinostat (PXD101) offers a practical entry point for studying how pan-HDAC activity connects chromatin acetylation, cell-cycle control, spliceosome regulation, and DNA-damage response. This thought-leadership article translates mechanistic findings from hepatocellular carcinoma research into a disciplined framework for bladder, prostate, and broader tumor-model studies.

• INO80 Enables Postreplicative DNA Gap Repair

  2026-09-14

  The reference study identifies the INO80 chromatin remodeller as a downstream facilitator of PCNA-dependent DNA damage bypass, supporting both daughter-strand gap expansion and subsequent gap filling. Its findings separate this activity from H2A.Z exchange, transcriptional regulation, and double-strand break repair, and support a model in which INO80 positions nucleosomes to provide access for repair enzymes.

• FLOT1–FOSL2–EphA2 Axis in AD Neuroinflammation

  2026-09-14

  The reference study identifies a FLOT1–FOSL2–EphA2 signaling axis that promotes pro-inflammatory microglial polarization through p38/MAPK signaling in Alzheimer’s disease models. Its combination of molecular interaction assays, transcriptional analysis, and APP/PS1 mouse experiments links this pathway to neuroinflammation and impaired spatial memory, while also defining important limits for translation to Aβ25-35-based systems.

• HotStart 2X Green qPCR Master Mix for DNMT3B

  2026-09-13

  Use a hot-start SYBR Green workflow to translate DNMT3B findings into reproducible cervical cancer expression assays. This guide combines assay setup, RNA-seq validation, controls, and troubleshooting for sensitive nucleic acid quantification without overstating what qPCR can prove.

• Lactylation–NSUN2 Drives PDAC Perineural Invasion

  2026-09-12

  A 2026 study identifies NSUN2 K692 lactylation as a metabolic switch that links lactate accumulation to RNA m5C-dependent stabilization of CDCP1 and STC1 in pancreatic ductal adenocarcinoma. By combining patient samples, mechanistic cell assays, nerve co-culture, and mouse models, the work explains how metabolic stress promotes perineural invasion and suggests intervention points for limiting neural tumor spread.

• Catalpol: From Pathway Pleiotropy to Assay Design

  2026-09-11

  Catalpol, also known as Catalpinoside, is a multi-target iridoid glycoside with applications spanning neuroprotection research and inflammatory disease models. This article converts its pathway biology into a practical, causally disciplined framework for selecting assays, controls, and preclinical endpoints.

• AI-10-49 Workflow for CBFβ-SMMHC AML Research

  2026-09-11

  AI-10-49 enables a mechanism-led workflow that connects CBFβ-SMMHC–RUNX1 dissociation with chromatin, transcriptional, survival, and animal-model readouts. Its strongest use case is inv(16) leukemia research, where target engagement can be paired with MYCN/eIF4G1 pathway analysis and carefully controlled phenotypic assays.

• FAISL–FAK Proteolysis in Triple-Negative Breast Cancer

  2026-09-10

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain-2-mediated proteolysis, thereby promoting triple-negative breast cancer progression and metastasis. Its combination of transcriptomic discovery, molecular interaction analysis, functional assays, and nanoparticle-mediated siRNA delivery establishes a mechanistic basis for targeting FAISL rather than FAK kinase activity alone.

• QPRT, PLC Signaling, and Breast Cancer Invasion

  2026-09-10

  Liu et al. showed that elevated quinolinate phosphoribosyltransferase (QPRT) is associated with invasive breast cancer and promotes migration and invasion through myosin light chain phosphorylation. Genetic perturbation and inhibitor-based experiments connected QPRT activity with purinergic, Rho–ROCK, PLC, and MLCK signaling, providing a mechanistic framework for studying breast cancer cell motility.

• Geneticin Beyond Selection: A Translational Strategy

  2026-09-09

  Geneticin, also known as G418 Sulfate, is more than a routine selection reagent. Its ribosomal mechanism, selective pressure profile, and reported antiviral activity create a translational framework for better cell-line development, assay design, and Dengue virus research. This article connects G418 workflows with transporter-aware experimental thinking while defining the boundaries between established evidence and forward-looking application.

• Annexin V-Cy5 Apoptosis Kit Workflow

  2026-09-09

  The Annexin V-Cy5 Apoptosis Kit provides a rapid way to separate phosphatidylserine exposure from lysosomal dysfunction in microglia experiments. This workflow combines flow cytometry apoptosis detection with fluorescence microscopy apoptosis analysis to test whether cellular stress reflects reversible adaptation or genuine cell death.

• Humanized Mice Improve CES Prodrug Translation

  2026-09-08

  The 2025 study of HD56 and HD561 shows how species-specific carboxylesterase activity can distort prodrug pharmacokinetics and weaken conventional in vivo–in vitro correlations. Humanized-liver mice produced the strongest translational relationship, supporting their use when human metabolic pathways are central to ester prodrug development.

8038 records 1/536 page Next 12345 下5页 Last page